MARCENARO, EMANUELA
 Distribuzione geografica
Continente #
EU - Europa 20.502
AS - Asia 2.181
NA - Nord America 1.324
SA - Sud America 166
AF - Africa 34
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 24.211
Nazione #
IT - Italia 20.068
US - Stati Uniti d'America 1.253
SG - Singapore 910
CN - Cina 617
VN - Vietnam 386
FR - Francia 192
BR - Brasile 109
HK - Hong Kong 73
FI - Finlandia 62
BD - Bangladesh 51
DE - Germania 43
JP - Giappone 39
GB - Regno Unito 38
CA - Canada 31
CH - Svizzera 25
AR - Argentina 24
MX - Messico 23
NL - Olanda 16
IQ - Iraq 15
PH - Filippine 13
TR - Turchia 13
IN - India 12
EC - Ecuador 10
ID - Indonesia 9
ES - Italia 7
PK - Pakistan 7
ZA - Sudafrica 7
IE - Irlanda 6
KR - Corea 6
RU - Federazione Russa 6
TH - Thailandia 6
MA - Marocco 5
BG - Bulgaria 4
BO - Bolivia 4
CL - Cile 4
CO - Colombia 4
DZ - Algeria 4
NO - Norvegia 4
PE - Perù 4
TN - Tunisia 4
UA - Ucraina 4
VE - Venezuela 4
AU - Australia 3
CR - Costa Rica 3
GT - Guatemala 3
JM - Giamaica 3
KE - Kenya 3
PL - Polonia 3
SE - Svezia 3
UZ - Uzbekistan 3
AL - Albania 2
AT - Austria 2
BH - Bahrain 2
CZ - Repubblica Ceca 2
EG - Egitto 2
ET - Etiopia 2
JO - Giordania 2
LT - Lituania 2
MD - Moldavia 2
MK - Macedonia 2
MY - Malesia 2
NI - Nicaragua 2
PS - Palestinian Territory 2
PT - Portogallo 2
PY - Paraguay 2
SA - Arabia Saudita 2
SI - Slovenia 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
AZ - Azerbaigian 1
BB - Barbados 1
BE - Belgio 1
CG - Congo 1
CY - Cipro 1
DJ - Gibuti 1
GA - Gabon 1
GF - Guiana Francese 1
GR - Grecia 1
HN - Honduras 1
IL - Israele 1
IR - Iran 1
LB - Libano 1
MT - Malta 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SO - Somalia 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZM - Zambia 1
Totale 24.211
Città #
Genova 11.514
Genoa 5.206
Rapallo 1.653
Vado Ligure 1.437
San Jose 480
Singapore 420
Lauterbourg 169
Beijing 120
Ho Chi Minh City 120
Ashburn 114
New York 92
Hanoi 87
Hong Kong 68
Council Bluffs 66
Helsinki 59
Bordighera 51
Santa Clara 49
Milan 48
Frankfurt am Main 40
Tokyo 36
Los Angeles 30
Rome 23
Haiphong 22
Zurich 22
Da Nang 19
Mexico City 15
Orem 15
Buffalo 13
Valenza 13
Tianjin 12
Catania 10
Montreal 10
Amsterdam 9
Cardiff 9
City of London 9
Phoenix 9
Des Moines 8
London 8
São Paulo 8
Boardman 7
Dallas 7
Shanghai 7
Baghdad 6
Dublin 6
Guayaquil 6
Hải Dương 6
Istanbul 6
Marseille 6
Naples 6
Bangkok 5
Basingstoke 5
Biên Hòa 5
Bologna 5
Brasília 5
Can Tho 5
Chicago 5
Piscataway 5
Turin 5
Atlanta 4
Bari 4
Bắc Ninh 4
Houston 4
Johannesburg 4
Manchester 4
Ninh Bình 4
Pasadena 4
Porto Alegre 4
Santa Rosa 4
Ankara 3
Cambridge 3
Charlotte 3
Chieti 3
Hyderabad 3
Karachi 3
Lappeenranta 3
Madrid 3
Miami 3
Minneapolis 3
Osasco 3
Paris 3
Quezon City 3
Rovereto 3
San Francisco 3
San José 3
Shenzhen 3
Sydney 3
The Bronx 3
Thái Bình 3
Thái Nguyên 3
Toronto 3
Warsaw 3
Washington 3
Addis Ababa 2
Agadir 2
Albuquerque 2
Algiers 2
Amman 2
As Samawah 2
Banbridge 2
Barcelona 2
Totale 22.329
Nome #
Different features of tumor-associated NK cells in patients with low-grade or high-grade peritoneal carcinomatosis 247
New miRNA signature heralds human NK cell subsets at different maturation steps: Involvement of miR-146a-5p in the regulation of KIR expression 230
Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization 221
B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape 218
Dysregulation of regulatory CD56bright NK cells/T cells interactions in multiple sclerosis 215
2B4 functions as a co-receptor in human NK cell activation 212
Bridging innate NK cell Functions with Adaptive Immunity. 203
IL-12 or IL-4 prime human NK cells to mediate functionally divergent interactions with dendritic cells or tumors 202
Features of Memory-Like and PD-1+ Human NK Cell Subsets 199
Uptake of CCR7 by KIR2DS4⁺ NK cells is induced upon recognition of certain HLA-C alleles 198
NK/DC crosstalk in anti-viral response. 197
Feasibility and Efficacy of Post-Transplant Consolidation Immunotherapy with Nivolumab Supported By the Reinfusion of Unselected Autologous Lymphocytes in Patients Affected By Relapsed/Refractory Hodgkin Lymphoma 194
Homophilic interaction of NTBA, a member of the CD2 molecular family: induction of cytotoxicity and cytokine release in human NK cells. 193
Characterization of CD56-/CD16+ natural killer (NK) cells: A highly dysfunctional NK subset expanded in HIV-infected viremic individuals. 189
TLR-stimulated neutrophils instruct NK cells to trigger dendritic cell maturation and promote adaptive T cell responses 185
An Historical Overview: The Discovery of How NK Cells Can Kill Enemies, Recruit Defense Troops, and More 184
B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape 183
Accumulation of Circulating CCR7+ Natural Killer Cells Marks Melanoma Evolution and Reveals a CCL19-Dependent Metastatic Pathway 181
Human NK Cell Subsets Redistribution in Pathological Conditions: A Role for CCR7 Receptor 180
Markers and function of human NK cells in normal and pathological conditions 179
PD-1 in human NK cells: evidence of cytoplasmic mRNA and protein expression 179
NK cells and their receptors during viral infections. 177
Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization 177
Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Refractory Hodgkin Lymphoma: A Feasible and Promising Salvage Therapy Associated With Expansion and Maturation of NK Cells 177
Harnessing NK Cells for Cancer Treatment 174
Homophilic interaction of NTBA, a member of the CD2 molecular family: induction of cytotoxicity and cytokine release in human NK cells 173
Multi-directional cross-regulation of NK cell function during innate immune responses. 170
Predictors of poor seroconversion and adverse events to SARS-CoV-2 mRNA BNT162b2 vaccine in cancer patients on active treatment 167
Human Natural Killer Cells exposed to IL-2, IL12, IL-18 or IL-4 differently modulate priming of naïve T cells by monocyte-derived Dendritic Cells. 166
The early expansion of anergic NKG2Apos/CD56dim/CD16neg natural killer cells represents a therapeutic target in haploidentical haematopoietic stem cell transplantation 166
CD56 as a marker of an ILC1-like population with NK cell properties that is functionally impaired in AML 166
Role of the 2B4 receptor in CD8+ T-cell-dependent immune control of Epstein-Barr virus infection in mice with reconstituted human immune system components 165
Human NK cell response to pathogens 165
CD59 is physically and functionally associated with natural cytotoxicity receptors and activates human NK cell-mediated cytotoxicity 163
Triggering receptors involved in natural killer cell-mediated cytotoxicity against choriocarcinoma cell lines 162
Adoptive Cell Therapy and Immune Check Points Inhibitors As a Salvage Treatment for Patient Affected By Relapsed/Refractory Hodgkin's Lymphoma 162
Uptake of CCR7 and acquisition of migratory properties by human KIR+ NK cells interacting with monocyte-derived DC or EBV cell lines: regulation by KIR/HLA-class I interaction. 158
Natural killer lymphocytes: "null cells" no more. 156
Homophilic interaction of NTBA, a member of the CD2 molecular family: induction of cytotoxicity and cytokine release in human NK cells 154
Priming of Human Resting NK Cells by Autologous M1 Macrophages via the Engagement of IL-1β, IFN-β, and IL-15 Pathways 154
Homophilic interaction of NTBA, a member of the CD2 molecular family: induction of cytotoxicity and cytokine release in human NK cells 153
PD/1-PD-Ls Checkpoint: Insight on the Potential Role of NK Cells 151
Involvement of natural cytotoxicity receptors in human natural killer cell-mediated lysis of neuroblastoma and glioblastoma cell lines 150
Molecular and functional characterization of IRp60, a member of the immunoglobulin superfamily that functions as an inhibitory receptor in human NK cells. 150
It's only innate immunity but I like it 150
NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells 149
Early expression of triggering receptors and regulatory role of 2B4 in human natural killer cell precursors undergoing in vitro differentiation. 149
Cancer immunotherapy by blocking immune checkpoints on innate lymphocytes 148
NK Cell-Based Immunotherapy in Colorectal Cancer 147
Human NK Cells Induce Neutrophil Apoptosis via an NKp46- and Fas-Dependent Mechanism. 146
Pathogen-induced private conversations between natural killer and dendritic cells 145
Innate immunity defects in Hermansky-Pudlak type 2 syndrome 145
Early liaisons between cells of the innate immune system in inflamed peripheral tissues 145
Targeting NKG2A to elucidate natural killer cell ontogenesis and to develop novel immune-therapeutic strategies in cancer therapy 145
Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Refractory Hodgkin Lymphoma: A Feasible and Promising Salvage Therapy Associated With Expansion and Maturation of NK Cells 144
Lysis of endogenously infected CD4+ T cell blasts by rIL-2 activated autologous natural killer cells from HIV-infected viremic individuals. 144
New miRNA signature heralds human NK cell subsets at different maturation steps: involvement of miR- 146a-5p in the regulation of KIR expression 143
Unraveling the regulatory role of NK cells on T-cell effector functions: Implications for CNS autoimmunity 142
Natural killer cell-triggering receptors in patients with acute leukaemia. 142
The role of chemerin in the co-localization of NK and dendritic cell subsets into inflamed tissues 141
Identification of NKG2A and NKp80 as specific Natural Killer cell markers in rhesus and pigtailed monkeys 141
Downregulation of HLA Class I Renders Inflammatory Neutrophils More Susceptible to NK Cell-Induced Apoptosis 141
CD94 functions as a natural killer cell inhibitory receptor for different HLA class I alleles: identification of the inhibitory form of CD94 by the use of novel monoclonal antibodies. 140
Primitive Neuroectodermal Tumor in an Ovarian Cystic Teratoma: Natural Killer and Neuroblastoma Cell Analysis 140
Homophilic interaction of NTBA, a member of the CD2 molecular family: induction of cytotoxicity and cytokine release in human NK cells 140
PD-1 is expressed by and regulates human group 3 innate lymphoid cells in human decidua 140
New Insights into Endometrial Cancer 140
Killer Ig-like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation. 139
miRNAs in NK Cell-Based Immune Responses and Cancer Immunotherapy 139
IL-12 or IL-4 prime human Natural Killer cells to mediate functionally divergent interactions with Dendritic cells or tumors 138
TLR/NCR/KIR: Which One to Use and When? 138
Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56bright NKG2A+++ Cells, and Yet Display Increased Degranulation and Higher Perforin Content. 138
The Innate Immune Cross Talk between NK Cells and Eosinophils Is Regulated by the Interaction of Natural Cytotoxicity Receptors with Eosinophil Surface Ligands 137
Adaptor protein 3 complex deficiency causes innate immunity defects 136
Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis 135
IL-12 or IL-4 prime human Natural Killer Cells to mediate functionally diverent interactions with dendritic cells or tumors 135
NK cell receptors in anti-tumor and healthy tissue protection: Mechanisms and therapeutic advances 134
IL-21 induces both rapid maturation of human CD34+ cell precursors towards NK cells and acquisition of surface killer Ig-like receptors 134
Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization 134
Regulatory Functions of Natural Killer Cells in Multiple Sclerosis 134
Human NK cells directly recognize Mycobacterium Bovis and acquire the ability to interact with monocyte-derived DC 133
IL-12 or IL-4 prime human natural killer cells to mediate functionally divergent interactions with dendritic cells or tumors 133
Human natural killer cells exposed to IL-2, IL-12, IL-18, or IL-4 differently modulate priming of naive T cells by monocyte-derived dendritic cells. 131
Role of alloreactive KIR2DS1+ NK cells in haploidentical hematopoietic stem cell transplantation. 131
Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences on the NK-mediated killing of dendritic cells 130
Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. 130
Human NK cells directly recognize Mycobacterium bovis and acquire the ability to interact with monocyte-derived DC 130
Natural killer cells in HIV-Infectious: Dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates. 129
The landscape of combining immune checkpoint inhibitors with novel Therapies: Secret alliances against breast cancer 127
The decreased expression of Siglec-7 represents an early marker of dysfunctional natural killer cell subsets associated with high levels of HIV-1 viremia. 127
Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia 127
Cognate HLA absence in trans diminishes human NK cell education 127
Human Natural Killer cells expressing high levels of Natural Citotoxicity Receptors (NCR) directly respond to Mycobacterium Bovis Bacillus Calmette-Guerin 127
Role of the main non HLA-specific activating NK receptors in pancreatic, colorectal and gastric tumors surveillance 127
Editorial: NK Cell Subsets in Health and Disease: New Developments 126
NK cells: innate immunity against hematological malignancies? 126
Comprehensive Phenotyping of Human PB NK Cells by Flow Cytometry 126
Harnessing Immune Response in Acute Myeloid Leukemia 125
Strengthening the AntiTumor NK Cell Function for the Treatment of Ovarian Cancer 125
NK-DC interaction: On the usefulness of auto-aggression 123
Totale 15.583
Categoria #
all - tutte 78.829
article - articoli 61.036
book - libri 695
conference - conferenze 8.875
curatela - curatele 0
other - altro 504
patent - brevetti 5.307
selected - selezionate 0
volume - volumi 2.412
Totale 157.658


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021135 0 0 0 0 0 0 0 0 0 0 0 135
2021/20222.122 77 160 151 183 116 118 142 495 156 186 95 243
2022/20232.047 238 154 23 194 297 348 4 178 381 21 178 31
2023/20241.164 63 177 34 136 93 122 80 125 69 48 80 137
2024/20253.516 76 260 133 229 511 337 363 501 117 191 375 423
2025/20266.037 706 177 420 479 766 603 960 298 464 632 378 154
Totale 24.710